Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-07 · accession 0000950170-25-106741 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2025-08-11 | 2025-08-07+ | BBIO | Kumar Neil | CEO, Dir | S - Sale | $45.84 | -80.0K | 4.75M | -2% | -$3.67M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-08 | S | D | 8,205 | $46.71 | 915,686 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F5) Represents the weighted average sale price of the shares sold from $46.49 to $47.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-08-08 | S | D | 11,795 | $45.88 | 923,891 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F4) Represents the weighted average sale price of the shares sold from $45.49 to $46.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-08-07 | S | D | 13,216 | $45.64 | 935,686 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F3) Represents the weighted average sale price of the shares sold from $45.31 to $46.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-08-07 | S | D | 6,784 | $45.09 | 948,902 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F2) Represents the weighted average sale price of the shares sold from $44.31 to $45.305 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2025-08-08 | S | D | 8,205 | $46.71 | 4,718,447 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F5) Represents the weighted average sale price of the shares sold from $46.49 to $47.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2025-08-08 | S | D | 11,795 | $45.88 | 4,726,652 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F4) Represents the weighted average sale price of the shares sold from $45.49 to $46.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2025-08-07 | S | D | 13,216 | $45.64 | 4,738,447 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F3) Represents the weighted average sale price of the shares sold from $45.31 to $46.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2025-08-07 | S | D | 6,784 | $45.09 | 4,751,663 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | — | — | (F2) Represents the weighted average sale price of the shares sold from $44.31 to $45.305 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |